Well Lead Med Co Ltd (603309) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Well Lead Med Co Ltd (603309) has a cash flow conversion efficiency ratio of 0.065x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.26 Million ≈ $18.48 Million USD) by net assets (CN¥1.95 Billion ≈ $284.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Well Lead Med Co Ltd to measure how much of total assets are equity-financed.
Well Lead Med Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Well Lead Med Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Well Lead Med Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Well Lead Med Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Well Lead Med Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Altia Consultores S.A.
MC:ALC
|
0.169x |
|
Paysign Inc
NASDAQ:PAYS
|
0.341x |
|
Anhui Gourgen Traffic Construction Co Ltd
SHG:603815
|
-0.050x |
|
Great Chinasoft Technology Co Ltd
SHE:002453
|
-0.023x |
|
LifeSemantics Corp.
KQ:347700
|
-0.313x |
|
Guangzhou Hangxin Aviation Technology Co Ltd
SHE:300424
|
0.071x |
|
Core Laboratories NV
NYSE:CLB
|
0.014x |
|
Amper S.A.
MC:AMP
|
-0.602x |
Annual Cash Flow Conversion Efficiency for Well Lead Med Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Well Lead Med Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Well Lead Med Co Ltd (603309) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.90 Billion ≈ $278.48 Million |
CN¥306.26 Million ≈ $44.82 Million |
0.161x | +26.59% |
| 2023-12-31 | CN¥1.84 Billion ≈ $268.80 Million |
CN¥233.51 Million ≈ $34.17 Million |
0.127x | -43.45% |
| 2022-12-31 | CN¥1.74 Billion ≈ $254.58 Million |
CN¥391.13 Million ≈ $57.23 Million |
0.225x | +91.04% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.89 Million |
CN¥187.28 Million ≈ $27.41 Million |
0.118x | -41.07% |
| 2020-12-31 | CN¥1.14 Billion ≈ $167.40 Million |
CN¥228.44 Million ≈ $33.43 Million |
0.200x | +15.76% |
| 2019-12-31 | CN¥1.04 Billion ≈ $151.66 Million |
CN¥178.79 Million ≈ $26.16 Million |
0.173x | +80.42% |
| 2018-12-31 | CN¥940.07 Million ≈ $137.56 Million |
CN¥89.89 Million ≈ $13.15 Million |
0.096x | +15.77% |
| 2017-12-31 | CN¥900.07 Million ≈ $131.71 Million |
CN¥74.34 Million ≈ $10.88 Million |
0.083x | -16.45% |
| 2016-12-31 | CN¥863.31 Million ≈ $126.33 Million |
CN¥85.35 Million ≈ $12.49 Million |
0.099x | -5.51% |
| 2015-12-31 | CN¥778.65 Million ≈ $113.94 Million |
CN¥81.47 Million ≈ $11.92 Million |
0.105x | -63.92% |
| 2014-12-31 | CN¥370.18 Million ≈ $54.17 Million |
CN¥107.34 Million ≈ $15.71 Million |
0.290x | +20.35% |
| 2013-12-31 | CN¥302.37 Million ≈ $44.25 Million |
CN¥72.85 Million ≈ $10.66 Million |
0.241x | -27.81% |
| 2012-12-31 | CN¥249.37 Million ≈ $36.49 Million |
CN¥83.23 Million ≈ $12.18 Million |
0.334x | +46.46% |
| 2011-12-31 | CN¥193.41 Million ≈ $28.30 Million |
CN¥44.08 Million ≈ $6.45 Million |
0.228x | -- |
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more